Prestige Wealth Management Group LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1772715 FLEMINGTON, NJ

Position in ARWR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,708

+$69 QoQ

Shares Held

107

+7.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Prestige Wealth Management Group LLC holds $563,805 across 26 Biotechnology names. ARWR ranks #6 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	847	$378,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	226	$74,776
3	REGN	Regeneron Pharmaceuticals, Inc.	63	$48,676
4	INCY	Incyte Corp	132	$12,423
5	MRNA	Moderna, Inc.	137	$6,959
6	ARWR	Arrowhead Pharmaceuticals, Inc. This page	107	$6,708
7	STOK	Stoke Therapeutics, Inc.	200	$6,512
8	ARQT	Arcutis Biotherapeutics, Inc.	250	$5,890

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,708	107	+7.0%	Shares	Other	2026-05-13
2025-12-31	$6,639	100	0.0%	Shares	Other	2026-02-11
2025-09-30	$3,449	100	-39.4%	Shares	Other	2026-02-20
2025-06-30	$2,607	165	+153.8%	Shares	Other	2026-02-20
2025-03-31	$828	65	0.0%	Shares	Sole	2026-02-20
2024-12-31	$1,222	65	0.0%	Shares	Sole	2026-02-20
2024-09-30	$1,259	65	+622.2%	Shares	Sole	2026-02-20
2022-03-31	$413	9	0.0%	Shares	Other	2022-05-05
2021-12-31	$596	9	+50.0%	Shares	Other	2022-02-15
2021-09-30	$374	6	—	Shares	Other	2021-11-12
No filing history on record for this holder in this stock.